Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
878 | 11463 | 27.7 | 46% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | NEBIVOLOL | authKW | 361492 | 2% | 62% | 219 |
2 | CARVEDILOL | authKW | 349682 | 3% | 37% | 352 |
3 | BETA BLOCKERS | authKW | 116389 | 3% | 12% | 375 |
4 | ATENOLOL | authKW | 96214 | 2% | 20% | 178 |
5 | METOPROLOL | authKW | 71859 | 1% | 19% | 146 |
6 | CELIPROLOL | authKW | 71816 | 0% | 50% | 54 |
7 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | journal | 67186 | 5% | 5% | 529 |
8 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | journal | 58235 | 4% | 5% | 423 |
9 | PHARMACOLOGY & PHARMACY | WoSSC | 56007 | 41% | 1% | 4736 |
10 | DOXAZOSIN | authKW | 48387 | 1% | 23% | 81 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 56007 | 41% | 1% | 4736 |
2 | Cardiac & Cardiovascular System | 30905 | 21% | 1% | 2427 |
3 | Medicine, General & Internal | 11530 | 16% | 0% | 1820 |
4 | Peripheral Vascular Diseases | 5619 | 7% | 0% | 823 |
5 | Chemistry, Analytical | 2406 | 8% | 0% | 878 |
6 | Medicine, Research & Experimental | 1709 | 6% | 0% | 655 |
7 | Chemistry, Medicinal | 1133 | 4% | 0% | 426 |
8 | Toxicology | 425 | 3% | 0% | 302 |
9 | Biochemical Research Methods | 250 | 3% | 0% | 294 |
10 | Physiology | 105 | 2% | 0% | 244 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EDUC NATIONALITIES | 7986 | 0% | 100% | 3 |
2 | PEDIAT PULMONOL CARDIOL | 7365 | 0% | 46% | 6 |
3 | CLIN PHARMACOKINET MODELING SIMULAT | 6838 | 0% | 43% | 6 |
4 | CLIN SCI STUDY OPERAT | 6081 | 0% | 57% | 4 |
5 | PHYSIOPATHOL CLIN BIOCHEM | 5982 | 0% | 38% | 6 |
6 | CLIN PHARM PHARMACOTHER Y UNITHLTH | 5324 | 0% | 100% | 2 |
7 | INT CLIN RD | 5324 | 0% | 100% | 2 |
8 | CLIN PHARMACOL STAT PROGRAMMING | 5113 | 0% | 38% | 5 |
9 | CARDIOL SPORT MED | 3824 | 0% | 24% | 6 |
10 | ORGAN CHEM 2250 KAWAGISHI | 3690 | 0% | 28% | 5 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 67186 | 5% | 5% | 529 |
2 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 58235 | 4% | 5% | 423 |
3 | CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 45408 | 3% | 6% | 287 |
4 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 36945 | 3% | 4% | 315 |
5 | ACTA MEDICA SCANDINAVICA | 32988 | 1% | 8% | 161 |
6 | CLINICAL PHARMACOLOGY & THERAPEUTICS | 20028 | 2% | 4% | 211 |
7 | DRUGS | 12507 | 1% | 3% | 164 |
8 | AMERICAN JOURNAL OF CARDIOLOGY | 12091 | 3% | 1% | 355 |
9 | AMERICAN HEART JOURNAL | 11800 | 2% | 2% | 256 |
10 | JOURNAL OF CLINICAL PHARMACOLOGY | 10208 | 1% | 3% | 146 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NEBIVOLOL | 361492 | 2% | 62% | 219 | Search NEBIVOLOL | Search NEBIVOLOL |
2 | CARVEDILOL | 349682 | 3% | 37% | 352 | Search CARVEDILOL | Search CARVEDILOL |
3 | BETA BLOCKERS | 116389 | 3% | 12% | 375 | Search BETA+BLOCKERS | Search BETA+BLOCKERS |
4 | ATENOLOL | 96214 | 2% | 20% | 178 | Search ATENOLOL | Search ATENOLOL |
5 | METOPROLOL | 71859 | 1% | 19% | 146 | Search METOPROLOL | Search METOPROLOL |
6 | CELIPROLOL | 71816 | 0% | 50% | 54 | Search CELIPROLOL | Search CELIPROLOL |
7 | DOXAZOSIN | 48387 | 1% | 23% | 81 | Search DOXAZOSIN | Search DOXAZOSIN |
8 | BOPINDOLOL | 46003 | 0% | 79% | 22 | Search BOPINDOLOL | Search BOPINDOLOL |
9 | NIPRADILOL | 40675 | 0% | 53% | 29 | Search NIPRADILOL | Search NIPRADILOL |
10 | PROPRANOLOL | 37071 | 2% | 8% | 176 | Search PROPRANOLOL | Search PROPRANOLOL |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | TODA, N , (2003) VASODILATING BETA-ADRENOCEPTOR BLOCKERS AS CARDIOVASCULAR THERAPEUTICS.PHARMACOLOGY & THERAPEUTICS. VOL. 100. ISSUE 3. P. 215-234 | 135 | 51% | 53 |
2 | FULTON, B , WAGSTAFF, AJ , SORKIN, EM , (1995) DOXAZOSIN - AN UPDATE OF ITS CLINICAL-PHARMACOLOGY AND THERAPEUTIC APPLICATIONS IN HYPERTENSION AND BENIGN PROSTATIC HYPERPLASIA.DRUGS. VOL. 49. ISSUE 2. P. 295-320 | 85 | 82% | 137 |
3 | IGNARRO, LJ , (2008) DIFFERENT PHARMACOLOGICAL PROPERTIES OF TWO ENANTIOMERS IN A UNIQUE BETA-BLOCKER, NEBIVOLOL.CARDIOVASCULAR THERAPEUTICS. VOL. 26. ISSUE 2. P. 115-134 | 55 | 90% | 40 |
4 | DE BOER, RA , VOORS, AA , VAN VELDHUISEN, DJ , (2007) NEBIVOLOL: THIRD-GENERATION BETA-BLOCKADE.EXPERT OPINION ON PHARMACOTHERAPY. VOL. 8. ISSUE 10. P. 1539-1550 | 60 | 85% | 13 |
5 | MCAINSH, J , CRUICKSHANK, JM , (1990) BETA-BLOCKERS AND CENTRAL-NERVOUS-SYSTEM SIDE-EFFECTS.PHARMACOLOGY & THERAPEUTICS. VOL. 46. ISSUE 2. P. 163-197 | 107 | 73% | 94 |
6 | JOHNSON, BF , DANYLCHUK, MA , (1989) THE RELEVANCE OF PLASMA-LIPID CHANGES WITH CARDIOVASCULAR DRUG-THERAPY.MEDICAL CLINICS OF NORTH AMERICA. VOL. 73. ISSUE 2. P. 449-473 | 98 | 91% | 21 |
7 | GAO, YS , VANHOUTTE, PM , (2012) NEBIVOLOL: AN ENDOTHELIUM-FRIENDLY SELECTIVE BETA 1-ADRENOCEPTOR BLOCKER.JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. VOL. 59. ISSUE 1. P. 16 -21 | 49 | 79% | 13 |
8 | GOA, KL , BENFIELD, P , SORKIN, EM , (1989) LABETALOL - A REAPPRAISAL OF ITS PHARMACOLOGY, PHARMACOKINETICS AND THERAPEUTIC USE IN HYPERTENSION AND ISCHEMIC HEART-DISEASE.DRUGS. VOL. 37. ISSUE 5. P. 583-627 | 117 | 72% | 31 |
9 | LARDINOIS, CK , NEUMAN, SL , (1988) THE EFFECTS OF ANTIHYPERTENSIVE AGENTS ON SERUM-LIPIDS AND LIPOPROTEINS.ARCHIVES OF INTERNAL MEDICINE. VOL. 148. ISSUE 6. P. 1280 -1288 | 94 | 78% | 158 |
10 | RABASSEDA, X , (1998) CARVEDILOL: AN EFFECTIVE ANTIHYPERTENSIVE DRUG WITH ANTIISCHEMIC/ANTIOXIDANT CARDIOPROTECTIVE PROPERTIES.DRUGS OF TODAY. VOL. 34. ISSUE 11. P. 905 -926 | 69 | 86% | 6 |
Classes with closest relation at Level 2 |